William Meury's Net Worth
$28.2 Million
Who is William Meury?
William Meury has an estimated net worth of $28.2 Million. This is based on reported shares across multiple companies, which include Syndax Pharmaceuticals Inc, Allergan plc, Forest Laboratories, LLC, and Karuna Therapeutics, Inc..
SEC CIK
William Meury's CIK is 0001536778
Past Insider Trading and Trends
2014 was William Meury's most active year for acquiring shares with 19 total transactions. William Meury's most active month to acquire stocks was the month of June. 2012 was William Meury's most active year for disposing of shares, totalling 30 transactions. William Meury's most active month to dispose stocks was the month of January. 2020 saw William Meury paying a total of $4,199,931.28 for 45,667 shares, this is the most they've acquired in one year. In 2018 William Meury cashed out on 130,519 shares for a total of $13,572,785.49, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $22.45
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +35.42% | 17K |
—
|
—
| 65K |
Feb 7
| |||
Form 4
|
—
|
0
|
$14.24 | -$1,032,560.00 | 48K |
Aug 2
| |||
Form 4
| +50.00% | 16K |
—
|
—
| 48K |
Feb 2
| |||
Form 4
| +100.00% | 16K |
—
|
—
| 32K |
Feb 2
| |||
Form 4
|
∞
| 16K |
—
|
—
| 16K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allergan plc No price found
EVP & Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -32.63K |
—
|
—
|
0
|
May 8
| |||
Form 4
| -2.55% | -855.00 |
$175.71 | -$150,232.05 | 32.63K |
Apr 3
| |||
Form 4
| +183.26% | 21.67K |
$193.84 | $4,199,931.28 | 33.49K |
Mar 2
| |||
Form 4
| -11.29% | -1.50K |
$191.17 | -$287,519.68 | 11.82K |
Dec 31
| |||
Form 4
| -6.13% | -871.00 |
$145.71 | -$126,913.41 | 13.33K |
Apr 3
| |||
Form 4
| -9.73% | -1.53K |
$133.66 | -$204,633.46 | 14.2K |
Dec 31
| |||
Form 4
| -16.79% | -3.17K |
$111.35 | -$2,328,387.03 | 15.73K |
Scheduled
|
May 17
| ||
Form 4
| -4.15% | -819.00 |
$164.74 | -$134,922.06 | 18.9K |
Apr 3
| |||
Form 4
| -13.92% | -35.27K |
$111.68 | -$7,965,632.48 | 218.1K |
Feb 14
| |||
Form 4
| -2.83% | -1.61K |
$163.58 | -$263,527.38 | 55.41K |
Dec 29
| |||
Form 4
|
—
|
0
|
$126.39 | -$1,121,783.07 | 57.02K |
Dec 1
| |||
Form 4
| +19.54% | 9.32K |
—
|
—
| 57.02K |
Oct 26
| |||
Form 4
| -1.22% | -587.00 |
$228.22 | -$133,965.14 | 47.7K |
May 15
| |||
Form 4
| +22.39% | 8.84K |
$237.68 | $2,099,902.80 | 48.29K |
Apr 3
| |||
Form 4
| +6.46% | 2.39K |
$148.80 | -$485,876.74 | 39.45K |
Dec 8
| |||
Form 4
| -3.19% | -1.22K |
$223.35 | -$273,157.05 | 37.06K |
May 15
| |||
Form 4/A
|
∞
| 47.16K |
—
|
—
| 47.16K |
Jul 1
| |||
Form 4
| -0.60% | -423.00 |
—
|
—
| 70.1K |
Dec 23
| |||
Form 4
| -2.60% | -1.88K |
$296.60 | -$557,904.60 | 70.52K |
May 15
| |||
Form 4
| -7.22% | -5.64K |
$296.19 | -$1,669,326.84 | 72.4K |
Apr 1
| |||
Form 4
| -0.13% | -98.00 |
—
|
—
| 78.04K |
Dec 18
| |||
Form 4
| -4.64% | -3.80K |
$266.59 | -$1,013,308.59 | 78.14K |
Dec 5 - Dec 6
| |||
Form 4
| +3.19% | 2.53K |
$179.60 | -$586,711.58 | 81.94K |
Nov 26
| |||
Form 4
|
∞
| 79.41K |
—
|
—
| 79.41K |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Forest Laboratories, LLC No price found
EVP - Sales and Marketing
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -91.47K |
—
|
—
|
0
|
Jul 1
| |||
Form 4
| -0.96% | -891.00 |
$92.23 | -$82,176.93 | 91.47K |
May 15
| |||
Form 4
| +10.16% | 8.52K |
—
|
—
| 92.36K |
May 13
| |||
Form 4
| -9.15% | -8.45K |
$56.34 | -$475,749.07 | 83.84K |
Dec 6 - Dec 7
| |||
Form 4
| -2.16% | -2.04K |
$55.87 | -$113,852.87 | 92.29K |
Dec 5
| |||
Form 4
| +16.41% | 13.3K |
—
|
—
| 94.33K |
May 21
| |||
Form 4
| -1.06% | -889.00 |
$38.88 | -$34,559.87 | 82.81K |
May 15
| |||
Form 4
|
—
|
0
|
$31.19 | -$239,359.97 | 81.92K |
Feb 6
| |||
Form 4
| -8.07% | -7.19K |
$35.78 | -$257,401.32 | 81.92K |
Dec 7 - Dec 8
| |||
Form 4
| -3.89% | -3.61K |
$35.83 | -$129,256.60 | 89.11K |
Dec 6
| |||
Form 4
| -2.10% | -1.99K |
$35.87 | -$71,309.56 | 92.72K |
Dec 5
| |||
Form 4
| +8.35% | 7.3K |
—
|
—
| 94.71K |
May 7
| |||
Form 4
| -32.38% | -41.85K |
$32.06 | -$1,341,672.79 | 87.41K |
Jan 18
| |||
Form 4
| +3.40% | 4.25K |
$30.04 | -$373,942.80 | 129.25K |
Dec 5 - Dec 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karuna Therapeutics, Inc. (KRTX) Snapshot price: $314.155
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -29.38K |
$330.00 | -$9,695,070.00 |
0
|
Mar 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| -22.84% | -8.69K |
$316.30 | -$2,749,912.20 | 29.38K |
Dec 28
| |||
Form 4
|
∞
| 38.07K |
—
|
—
| 38.07K |
Jan 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||